These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2638994)

  • 1. [Saliva phenobarbital concentration in epileptics].
    Shen D
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):369-70, 382. PubMed ID: 2638994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and serum concentrations, and protein binding of carbamazepine in young epileptic patients.
    Paxton JW
    Methods Find Exp Clin Pharmacol; 1983; 5(6):397-401. PubMed ID: 6621183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
    Vasudev A; Tripathi KD; Puri V
    Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary antiepileptic drug levels in Thai children.
    Kankirawatana P
    J Med Assoc Thai; 1999 Jan; 82(1):80-8. PubMed ID: 10087743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.
    Cook CE; Amerson E; Poole WK; Lesser P; O'Tuama L
    Clin Pharmacol Ther; 1975 Dec; 18(6):742-7. PubMed ID: 1204279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on cerebrospinal fluid and saliva to serum concentration ratios of anticonvulsants--Phenytoin, Phenobarbital, Valproic Acid and Primidone in epileptic patients].
    Kido H
    Seishin Shinkeigaku Zasshi; 1982; 84(9):661-79. PubMed ID: 6820506
    [No Abstract]   [Full Text] [Related]  

  • 7. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the saliva and free serum concentration of phenobarbital in epileptic children.
    Tokugawa K; Ueda K; Fujito H; Kurokawa T
    Eur J Pediatr; 1986 Oct; 145(5):401-2. PubMed ID: 3792385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of phenobarbital and diphenylhydantoin on some blood cation transport systems in epileptics.
    Mison-Crighel N; Pintilie C; Florescu D; Tudor S; Volanschi D
    Rev Roum Neurol; 1973; 10(5):451-9. PubMed ID: 4758239
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbamazepine serum levels in epileptics. Influence of age, sex, body weight and interaction with phenobarbital.
    De Michele G; Brescia Morra V; Pisanti N; Giani U; Filla A; Sinisi L; Capone D; Campanella G
    Acta Neurol (Napoli); 1985; 7(3-4):228-34. PubMed ID: 4061136
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal study of phenobarbital in serum, cerebrospinal fluid, and saliva in the dog.
    Skinner SF; Robertson LT; Artero M; Gerding RK
    Am J Vet Res; 1980 Apr; 41(4):600-4. PubMed ID: 7406279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
    Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of dimethoxymethyl phenobarbital (eterobarb) in patients with epilepsy.
    Goldberg MA; Gal J; Cho AK; Jenden DJ
    Ann Neurol; 1979 Feb; 5(2):121-6. PubMed ID: 426475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between quinidine concentrations measured in saliva and erythrocytes, and in serum.
    Yosselson-Superstine S; Yanuka Y; Ishai S
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):181-6. PubMed ID: 7076348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the phenobarbital content in the saliva of epileptic patients].
    Loiseau P; Brachet-Liermain A; Henry P
    Nouv Presse Med; 1976 Feb; 5(8):492-4. PubMed ID: 4773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rise in gamma-GT during anticonvulsive therapy].
    Deisenhammer E; Schwarzbach H; Sommer R
    Wien Klin Wochenschr; 1982 Nov; 94(21):584-5. PubMed ID: 6132495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily salivary anticonvulsant monitoring in patients with intractable epilepsy.
    Herkes GK; Eadie MJ
    Clin Exp Neurol; 1989; 26():141-9. PubMed ID: 2642124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma.
    Aviram M; Tal A; Ben-Zvi Z; Gorodischer R
    Pediatrics; 1987 Dec; 80(6):894-7. PubMed ID: 3684402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.